Presented by: Tom L. Rosamond, MD, MSc, FAHA, FACC, FASE
This study will demonstrate the value of Cardiac PET/CT with N-13 Ammonia for the assessment of hypertrophic cardiomyopathy.
Dr. Thomas Rosamond is Board Certified in Cardiovascular Disease. Dr. Rosamond is the Division Chief of Cardiovascular Imaging and Medical Director of Non-Invasive Imaging Services at The University of Kansas Health System. He earned his Postdoctoral Fellowship in Cardiovascular Magnetic Resonance Imaging at Washington University School of Medicine -Barnes Jewish Hospital in St. Louis, Missouri.
